Search Results - Armstrong, A J
- Showing 1 - 9 results of 9
-
1
-
2
-
3
Effect of Prophylactic Calcitriol Administration on Serum Ionized Calcium Concentrations after Parathyroidectomy: 78 Cases (2005–2015) by Armstrong, A.J., Hauptman, J.G., Stanley, B.J., Klocke, E., Burneko, M., Holt, D.E., Runge, J.J., Rubin, J.A.
Published 2017Text -
4
Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer by Armstrong, A J, Lin, P, Higano, C S, Sternberg, C N, Sonpavde, G, Tombal, B, Templeton, A J, Fizazi, K, Phung, D, Wong, E K, Krivoshik, A, Beer, T M
Published 2018Text -
5
Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration-Resistant Prostate Can... by Armstrong, A.J., Häggman, M., Stadler, W.M., Gingrich, J.R., Assikis, V., Polikoff, J., Damber, J.E., Belkoff, L., Nordle, Ö., Forsberg, G., Carducci, M.A., Pili, R.
Published 2013Text -
6
Distinct routes to metastasis: plasticity-dependent and plasticity-independent pathways by Somarelli, J A, Schaeffer, D, Marengo, M S, Bepler, T, Rouse, D, Ware, K E, Hish, A J, Zhao, Y, Buckley, A F, Epstein, J I, Armstrong, A J, Virshup, D M, Garcia-Blanco, M A
Published 2016Text -
7
Development and Validation of Circulating Tumor Cell Enumeration (Epic Sciences) as a Prognostic Biomarker in Men with Metastatic Castration Resistant Prostate Cancer by Scher, H I, Armstrong, A J, Schonhoft, J D, Gill, A, Zhao, J L, Barnett, E, Carbone, E, Lu, J, Antonarakis, E S, Luo, J, Tagawa, S, dos Anjos, C H, Yang, Q, George, D, Szmulewitz, R, Danila, D C, Wenstrup, R, Gonen, M, Halabi, S
Published 2021Text -
8
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy by Beer, T.M., Armstrong, A.J., Rathkopf, D.E., Loriot, Y., Sternberg, C.N., Higano, C.S., Iversen, P., Bhattacharya, S., Carles, J., Chowdhury, S., Davis, I.D., de Bono, J.S., Evans, C.P., Fizazi, K., Joshua, A.M., Kim, C.-S., Kimura, G., Mainwaring, P., Mansbach, H., Miller, K., Noonberg, S.B., Perabo, F., Phung, D., Saad, F., Scher, H.I., Taplin, M.-E., Venner, P.M., Tombal, B.
Published 2014Text -
9
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet by Armstrong, A J, Antonarakis, E S, Taplin, M -E, Kelly, W K, Beltran, H, Fizazi, K, Dahut, W L, Shore, N, Slovin, S, George, D, Carducci, M A, Corn, P, Danila, D, Dreicer, R, Heath, E, Rathkopf, D, Liu, G, Nanus, D, Stein, M, Smith, M R, Sternberg, C, Wilding, G, Nelson, P S, Halabi, S, Kantoff, P, Clarke, N W, Evans, C P, Heidenreich, A, Mottet, N, Gleave, M, Morris, M J, Scher, H I
Published 2018Text